November 17-19: Meeting
DIA is offering both a live in-person conference or an On Demand Library for the DIA Canadian Annual Meeting that allows you to view all the session recordings from the comfort of your own home/office at your own pace. Upon registration, please indicate via the check box which avenue you are registering for: in-person or on demand.
The DIA Canadian Annual Meeting will deliver a comprehensive overview of the current biopharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships, to key regulatory, clinical, and safey considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe. This meeting presents three tracks: Regulatory, Clinical, and Pharmacovigilance. Our new pharmacovigilance track, previously its own meeting, broadens the scope of this meeting and will provide additional insights, education and knowledge sharing for our attendees to discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.
While we prepare for the 2022 DIA Canadian Annual Meeting check out our 2021 Program.
Who should attend?
- Clinical Data Management/eClinical
- Comparative Effectiveness/Health Technology Assessment
- Clinical Safety/Pharmacovigilance
- Clinical Research
- Document Management/eSubmissions
- Medical Communications
- Project Management
- Public Policy/Law/Corporate Compliance
- Quality Assurance Control
- Regulatory Affairs
- Research and Development